Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 17, 2012, Pages 6656-6661

  Edris, Badreddin ^a,b   Weiskopf, Kipp ^a   Volkmer, Anne K ^a   Volkmer, Jens Peter ^a   Willingham, Stephen B ^a   Contreras Trujillo, Humberto ^a   Liu, Jie ^a   Majeti, Ravindra ^a   West, Robert B ^a   Fletcher, Jonathan A ^c   Beck, Andrew H ^d   Weissman, Irving L ^a   Van De Rijn, Matt ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SIZE; CARCINOGENICITY; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEIOMYOSARCOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MACROPHAGE; METASTASIS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS, CD47; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; IMMUNOTHERAPY; LEIOMYOSARCOMA; MICE; NEOPLASM METASTASIS; PHAGOCYTOSIS;

EID: 84860135764     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121629109     Document Type: Article

References (23)

1. Evans HL, Shipley J (2002) Pathology and Genetics of Tumours of Soft Tissue and Bone -World Health Organization Classification of Tumours, eds Fletcher CDM, Unni KK, Mertens F (IARC Press, Lyon), pp 131-134.
2. Coindre JM, et al. (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91:1914-1926.
3. Blay JY, et al. (2003) Advanced soft-tissue sarcoma: A disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer 39:64-69.
4. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor micro-environments. Cancer Res 66:605-612. (Pubitemid 43165918)
5. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51.
6. Jaiswal S, Chao MP, Majeti R, Weissman IL (2010) Macrophages as mediators of tumor immunosurveillance. Trends Immunol 31:212-219.
7. Lee CH, et al. (2008) Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 14:1423-1430. (Pubitemid 351413925)
8. Espinosa I, et al. (2009) Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma. Am J Pathol 174:2347-2356.
9. Espinosa I, et al. (2011) CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. Am J Pathol 179:2100-2107.
10. Kubota Y, et al. (2009) M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206:1089-1102.
11. Brown EJ, Frazier WA (2001) Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11:130-135. (Pubitemid 32289443)
12. Barclay AN, Brown MH (2006) The SIRP family of receptors and immune regulation. Nat Rev Immunol 6:457-464.
13. Jaiswal S, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138:271-285.
14. Majeti R, et al. (2009) CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138:286-299.
15. Chao MP, et al. (2010) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142:699-713.
16. Chao MP, et al. (2010) Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2:63ra94.
17. Chao MP, et al. (2011) Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 71:1374-1384.
18. Ito M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182. (Pubitemid 35217065)
19. Cameron MD, et al. (2000) Temporal progression of metastasis in lung: Cell survival, dormancy, and locationdependence ofmetastatic inefficiency. Cancer Res 60:2541-2546. (Pubitemid 30262450)
20. Chen Q, Zhang XH, Massagué J (2011) Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 20:538-549.
21. Beck AH, et al. (2010) Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene 29:845-854.
22. Sherlock G, et al. (2001) The Stanford Microarray Database. Nucleic Acids Res 29: 152-155. (Pubitemid 32054432)
23. Ueno H, Weissman IL (2006) Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood islands. Dev Cell 11:519-533. (Pubitemid 44430897)